Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer’s disease

Alzheimer's disease (AD) is responsible for the most common form of dementia among elderly people. Signature features of the AD brain are intra/extracellular deposits of beta-amyloid (Abeta) and neurofibrillary tangles composed of hyperphosphorylated tau. Recent evidence indicates that in AD altered Zn(2+) homeostasis can play an important role in the development of the disease as the cation promotes Abeta oligomerization and plaque formation. In this study, we investigated whether intraneuronal Zn(2+) homeostasis is affected by known "pro-AD factors" such as mutant forms of the amyloid precursor (APP), presenilin-1 (PS1), and tau proteins. Oxidative stress is a potent trigger for mobilization of intracellular free Zn(2+) ([Zn(2+)](i)) and we therefore evaluated ROS-driven [Zn(2+)](i) rises in neurons obtained from triple transgenic AD mice (3xTg-AD) that express mutant APP, PS1 and tau. In this study, [Zn(2+)](i) rises triggered by prolonged exposure to the membrane-permeant oxidizing agent 2,2'-dithiodipyridine were found to be significantly higher in 3xTg-AD neurons when compared to control cultures, suggesting that neuronal expression of pro-AD factors can facilitate altered Zn(2+) homeostasis.

[1]  M. Aschner.  The functional significance of brain metallothioneins , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[3]  F. LaFerla,et al.  A dynamic relationship between intracellular and extracellular pools of Abeta. , 2006, The American journal of pathology.

[4]  F. LaFerla,et al.  Reduction of Soluble Aβ and Tau, but Not Soluble Aβ Alone, Ameliorates Cognitive Decline in Transgenic Mice with Plaques and Tangles* , 2006, Journal of Biological Chemistry.

[5]  Sensi Sl,et al.  Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. , 2004 .

[6]  D. Selkoe,et al.  The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. , 2000, Biochemistry.

[7]  A. Bush,et al.  The neurobiology of zinc in health and disease , 2005, Nature Reviews Neuroscience.

[8]  E. Mocchegiani,et al.  Interrelationships among brain, endocrine and immune response in ageing and successful ageing: role of metallothionein III isoform , 2003, Mechanisms of Ageing and Development.

[9]  B. Kristal,et al.  Zinc Irreversibly Damages Major Enzymes of Energy Production and Antioxidant Defense Prior to Mitochondrial Permeability Transition* , 2007, Journal of Biological Chemistry.

[10]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[11]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[12]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[13]  M. S. Effron,et al.  Zn2+ inhibits alpha-ketoglutarate-stimulated mitochondrial respiration and the isolated alpha-ketoglutarate dehydrogenase complex. , 2000, The Journal of biological chemistry.

[14]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[15]  R. Palmiter,et al.  Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury , 2003, Experimental Neurology.

[16]  K. Gee,et al.  Measuring zinc in living cells. A new generation of sensitive and selective fluorescent probes. , 2002, Cell calcium.

[17]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[18]  C. Franceschi,et al.  Association studies on human mitochondrial DNA: methodological aspects and results in the most common age-related diseases. , 2007, Mitochondrion.

[19]  Jae-Young Koh,et al.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Fattoretti,et al.  Zinc-bound metallothioneins as potential biological markers of ageing , 2001, Brain Research Bulletin.

[21]  W. Maret,et al.  Zinc and Health: Current Status and Future Directions The Function of Zinc Metallothionein: A Link between Cellular Zinc and Redox State 1,2 , 2000 .

[22]  L. Kaczmarek,et al.  Modulation of mitochondrial function by endogenous Zn2+ pools , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.

[24]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[25]  W. Markesbery,et al.  Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease , 2009, Neurotoxicity Research.

[26]  S. Lipton,et al.  Crosstalk between Nitric Oxide and Zinc Pathways to Neuronal Cell Death Involving Mitochondrial Dysfunction and p38-Activated K+ Channels , 2004, Neuron.

[27]  S. Sensi,et al.  Preferential Zn 2 1 influx through Ca 2 1-permeable AMPA y kainate channels triggers prolonged mitochondrial superoxide production , 1999 .

[28]  S. Sensi,et al.  Mild Acidosis Enhances AMPA Receptor-Mediated Intracellular Zinc Mobilization in Cortical Neurons , 2007, Molecular medicine.

[29]  D. Wallace.  A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.

[30]  Fiorella Marcellini,et al.  Brain, aging and neurodegeneration: Role of zinc ion availability , 2005, Progress in Neurobiology.

[31]  J. D. McGaugh,et al.  Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice , 2005, Neuron.

[32]  J. Koh,et al.  The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice , 2004, Neurobiology of Aging.

[33]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[34]  V. Haroutunian,et al.  Elevated cortical zinc in Alzheimer disease , 2006, Neurology.

[35]  W. Markesbery,et al.  Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease , 2006, Journal of neuropathology and experimental neurology.

[36]  K. Davis,et al.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.

[37]  M. S. Effron,et al.  Zn2+ Inhibits α-Ketoglutarate-stimulated Mitochondrial Respiration and the Isolated α-Ketoglutarate Dehydrogenase Complex* , 2000, The Journal of Biological Chemistry.

[38]  F. LaFerla,et al.  Copyright © American Society for Investigative Pathology DOI: 10.2353/ajpath.2006.050593 Molecular Pathogenesis of Genetic and Inherited Diseases A Dynamic Relationship between Intracellular and Extracellular Pools of A� , 2022 .

[39]  B. McLaughlin,et al.  Induction of Neuronal Apoptosis by Thiol Oxidation , 2000, Journal of neurochemistry.

[40]  C. Bertoni‐Freddari,et al.  Metallothionein isoforms (I+II and III) and interleukin-6 in the hippocampus of old rats: may their concomitant increments lead to neurodegeneration? , 2004, Brain Research Bulletin.

[41]  G. Kerchner,et al.  Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry , 1997, The Journal of Neuroscience.

[42]  C. Finch,et al.  Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Maret,et al.  The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Masters,et al.  Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice , 2001, Neuron.

[45]  S. Sensi,et al.  Mechanism and Regulation of Cellular Zinc Transport , 2007, Molecular medicine.

[46]  I. Reynolds,et al.  Direct visualization of mitochondrial zinc accumulation reveals uniporter‐dependent and ‐independent transport mechanisms , 2005, Journal of neurochemistry.